investigational protease inhibitor, Aptivus (tipranavir)

You'll hear about an investigational protease inhibitor, Aptivus (tipranavir).

It's the first NON-peptidic protease inhibitor (PI).

PIs have trouble adapting their shape when HIV protease enzymes mutate. Aptivus is more "flexible"...hopefully making it harder for resistance to develop.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote